亞太地區(qū)大腸癌篩查共識會議

AsiaPacificConsensusMeetingonColorectalCancerScreening

亞太地區(qū)大腸癌篩查共識會議

ConsensusStatements聲明共識VotingParticipants

投票者

Totalnumberofeligiblevotingparticipants:總合資格投票人數(shù)

:60Numberofvotesreceivedforthe1stround:第一輪得票數(shù):

50Numberofparticipantsabstainedfromvoting(includingthosewhowon’tparticipateinthe2ndand/or3rdround):棄權(quán)人數(shù)（包括不參加第二輪和/或第三輪投票者）:

10Participantseligibleforthe2ndand3rdvoting:第二輪和第三輪合資格投票人數(shù):

50Epidemiology–Statement1

流行病學—聲明1ColorectalCancer(CRC)isoneofthemostcommoncancersinAsiainbothmalesandfemales.

大腸癌是亞洲男、女性最?；嫉陌┌Y之一。

Level:II-3,AEpidemiology–Statement2

流行病學—聲明2TheincidenceofCRCissimilartothatoftheWest.大腸癌發(fā)病率與西方國家的發(fā)病率相似。Level:II-3,BEpidemiology–Statement3

流行病學—聲明3TheincidenceofadvancedneoplasminsymptomaticandasymptomaticAsianiscomparabletotheWest.

亞洲患者中有癥狀和無癥狀的晚期腫瘤發(fā)病率與西方國家相似。

Level:II-2,BEpidemiology–Statement4

流行病學—聲明4WhilethedeathrateofCRCisdecliningintheWest,Asiacontinuestoshowrisingmortality.

雖然西方國家的大腸癌死亡率呈下降趨勢，亞洲國家的大腸癌死亡率仍持續(xù)攀升。

Level:III,CEpidemiology–Statement5

流行病學—聲明5Therearesomeethnicgroups(e.g.Japanese,KoreanandChinese)inAsiawhoaremoresusceptibletoCRC.亞洲某些人種（例如：日本、韓國和中國），較其他人更易患大腸癌。Level:II-2,BPolyps–Statement6

息肉—聲明6DistributionofpolypsbetweenAsianandCaucasiansaresimilar.亞洲人和白種人的息肉分佈情況相似。Level:II-2,BPolyps–Statement7

息肉—聲明7ThereisatrendtowardsproximalmigrationofpolypsinthecoloninAsiansubjects.在亞洲患者中，大腸息肉的近端遷移呈上升趨勢。Level:III,CPolyps–Statement8

息肉—聲明8Non-polypoidadenomaisnotuncommonamongAsians.非息肉樣腺瘤在亞洲並非罕見疾病

。Level:II-2,APolyps–Statement9

息肉—聲明9Certaintypesofhyperplasticpolypsareassociatedwithanincreasedriskofcancer.某些特定增生性息肉患者大腸癌的發(fā)病風險較高。Level:II-3,APolyps–Statement10

息肉—聲明10Polyp5-9mminsizeshouldberemoved.5-9毫米的息肉應切除。Level:III,CScreeningTest–Statement11

篩查—聲明11FOBT(guaiac-basedtestandimmunochemicaltest),FlexiblesigmoidoscopyandColonoscopycanberecommendedforCRCscreening.大便隱血測試（愈創(chuàng)木脂檢測法和免疫化學檢測法），軟式乙狀結(jié)腸鏡和結(jié)腸鏡可作為大腸癌篩查的推薦方法。Level:I,AScreeningTest–Statement12

篩查—聲明12DoublecontrastbariumenemaisnotapreferredCRCscreeningtest.鋇灌腸雙重造影術(shù)不適合作為大腸癌篩查的首推檢測方法。Level:III,CScreeningTest–Statement13

篩查—聲明13CTColonographyisnotcurrentlyapreferredCRCscreeningtest.目前，CT結(jié)腸成像術(shù)不適合作為大腸癌篩查的首推檢測方法。Level:III,CScreeningTest–Statement14

篩查—聲明14Inresourcelimitedcountries,FOBTisthefirstchoiceforCRCscreening.在資源有限的國家，大便隱血測試應為大腸癌篩查的首選方法。Level:I,CScreeningTest–Statement15

篩查—聲明15Followinganegativecolonoscopy,arepeatexaminationshouldbeperformedin10years.結(jié)腸鏡檢驗呈陰性結(jié)果的患者，10年內(nèi)應重複檢查。Level:II-3,CRiskStratification–Statement16

危險級別—聲明16Theage-adjustedincidenceofCRCishigherinmenthanwomen.大腸癌的年齡別發(fā)病率，男性高於女性。

Level:II-2,ARiskStratification–Statement17

危險級別—聲明17CRCscreeningshouldbeginattheageof50.50歲後應該開始進行大腸癌篩查。Level:II-2,BRiskStratification–Statement18

危險級別—聲明18FirstdegreerelativestopatientswithCRCareatanincreasedriskandthusshouldreceivescreeningearlier.大腸癌患者的近親屬患病風險高，應更早接受大腸癌篩查。

Level:III,CRiskStratification–Statement19

危險級別—聲明19SmokingincreasesriskofCRC.吸煙增加大腸癌風險。Level:II-2,BRiskStratification–Statement20

危險級別—聲明20ObesityincreasesriskofCRC.肥胖增加大腸癌風險。Level:II-2,AStrategic

Recommendations–Statement21

策略建議—聲明21ScreeningforCRCshouldbeanationalhealthpriorityinmostAsiancountries.在大多數(shù)亞洲國家，大腸癌的篩查應該提升為國家健康重點問題。Level:III,CStrategic

Recommendations–Statement22

策略建議—聲明22

ResearchonbarrierstoCRCscreeningshouldbeconductedinvariousAsiancountries.在亞洲國家，應該積極進行關於大腸癌篩查障礙的研究。Level:II-3,BStrategic

Recommendations–Statement23

策略建議—聲明23EducationofthepublicisessentialinpromotingCRCscreening.推動大腸癌篩查的重點應在於普及公眾教育。

Level:I,AStrategic

Recommendations–Statement24

策略建議—聲明24FamilyPhysiciansshouldbeengagedinpromotingCRCscreening.家庭全科醫(yī)生應加入大腸癌篩查的